2nd Workshop Joint EUSICA + IMMUNO-model Workshop: Fostering collaboration to advance sinonasal cancer research and endoscopic sinus and skull base surgery took places on May 3-4, 2023 in hybrid format at the Rigshospitalet, Copenhagen, Denmark. There were 59 participants, mainly researchers and clinicians.
Local Organizers: Christian von Buchwald and Patrick René Gerhard Eriksen from the Rigshospitalet, Copenhagen, Denmark
The Workshop focused on sinonasal tumours, a rare and heterogeneous malignancy, presenting different histological features and clinical behaviour affecting fewer than 1 person out of 100,000 individuals per year worldwide. Although there are no standard or evidence-based therapeutic strategies, immunotherapy may have a role in some types of sinonasal cancers. In this regard, pre-clinical models of sinonasal cancer that are able to test their sensibility to this kind of treatments may boost research in the field. Clinical and translational research aspects in this type of tumours were discussed and IMMUNO-model brought its experience in preclinical models in immuno-oncology. The aim of the workshop was to foster research in this type of tumours and to establish future collaborations with EUSICA. A conference report was published as a result (PMID: 37573683)
Scientific committee:
Christian von Buchwald, Rigshospitalet, Copenhagen, Denmark
Eva Martinez-Balibrea, Catalan Institute of Oncology and Germans Trias i Pujol Research Institute, Badalona, Spain
Matt Lechner, Cancer Institute, University College London, London, UK
Mario Hermsen, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Spain
Leticia Oliveira Ferrer, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
